ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Los Angeles, CA, USA:

A Phase 2 Study of PCS6422 with Capecitabine in Patients with Advanced or Metastatic Breast Cancer

standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...

Enrolling
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Capecitabine
Drug: PCS6422 and capecitabine

Phase 2

Processa Pharmaceuticals

Los Angeles, California, United States of America and 2 other locations

(ICI) on on 3-year Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") resectable breast...

Enrolling
Breast Cancer
Procedure: Breast Surgery
Drug: Pembrolizumab

Phase 2

The University of Texas System (UT)
The University of Texas System (UT)

Los Angeles, California, United States and 3 other locations

A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of C...

Enrolling
Breast Cancer Stage IV
Breast Cancer
Drug: MBQ-167

Phase 1

MBQ Pharma

Beverly Hills, California, United States and 3 other locations

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Enrolling
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

Los Angeles, California, United States and 4 other locations

Status recently updated

to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...

Enrolling
Active, not recruiting
Locally Advanced Breast Cancer
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

SCRI Development Innovations

Duarte, California, United States and 10 other locations

in combination with either of two chemotherapy regimens (weekly paclitaxel or capecitabine) in unresectable/metastatic triple negative breast...

Active, not recruiting
Triple Negative Breast Cancer
Drug: Paclitaxel
Drug: Capecitabine

Phase 1, Phase 2

Providence Health & Services
Providence Health & Services

Los Angeles, California, United States of America and 1 other location

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

Santa Monica, California, United States and 8 other locations

This trial will evaluate the use of immunotherapy and PARP inhibition in a population with incurable advanced breast cancer associa ...

Active, not recruiting
Breast Cancer
Drug: Olaparib
Drug: Pembrolizumab

Phase 2

Yuan Yuan

Los Angeles, California, United States of America

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

Santa Monica, California, United States and 35 other locations

A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, stage II-III, Estrogen Rec ...

Enrolling
Breast Cancer
Drug: Adjuvant Therapy
Drug: Palbociclib

Phase 2

Criterium

Los Angeles, California, United States and 14 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems